Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Jefferies raises Doximity price target to $43 from $35, keeps buy rating

EditorLina Guerrero
Published 20/08/2024, 20:58
DOCS
-

On Tuesday, Jefferies maintained a Buy rating on Doximity Inc (NYSE:DOCS) and increased the price target to $43.00 from the previous $35.00. This adjustment comes in the wake of the company's first-quarter results and updated fiscal year 2025 guidance. The firm acknowledges the promising early performance in fiscal year 2025, highlighting the initial success of new product introductions and the Client Portal.

Doximity's recent quarter's outcomes have prompted Jefferies to revise their financial model for the company. The updated guidance provided by Doximity for fiscal year 2025 appears to have been a significant factor in the firm's reassessment. The positive adjustment in the price target reflects a confidence in the company's growth trajectory.

The analyst specifically noted the Client Portal's early traction as a positive indicator. Despite only approximately 30% of clients currently having access to this feature, the firm anticipates this to be a driving force for Doximity's long-term growth. The Client Portal is seen as a key component in the company's strategy to expand its client base and enhance user engagement.

Jefferies' optimism is also rooted in the company's performance with its new products. The successful launch and adoption of these products are seen as critical to Doximity's continued expansion and ability to meet the evolving needs of its clients.

The firm concluded its remarks by reiterating its Buy rating for Doximity Inc. The stance taken by Jefferies suggests a positive outlook on the company's future financial performance and its potential for growth in the coming years.

In other recent news, Doximity Inc has been the focus of several analyst firms following its robust financial performance. Canaccord Genuity maintained a Buy rating on Doximity, expressing confidence in the company's new Portal offering and its potential to significantly impact long-term growth and market share.

Truist Securities increased its FY25 revenue estimate for Doximity to $522.8 million, while Piper Sandler raised its price target for Doximity to $31.00, influenced by the company's strong earnings.

Needham upgraded its rating on Doximity to Buy, citing strong momentum with large customers and new product innovations. The firm set a price target of $38.00 for the company's shares. However, Wells Fargo downgraded Doximity's shares and reduced the price target to $19.00, citing concerns over the company's growth trajectory.

Evercore ISI increased the price target for Doximity to $34.00, following the company's robust financial results. The company's recent performance has been bolstered by significant growth and engagement, with new product offerings seeing substantial growth. These are recent developments that have emerged from the company's recent earnings report and financial performance.

InvestingPro Insights

Following the optimistic perspective from Jefferies on Doximity Inc (NYSE:DOCS), InvestingPro data further enriches the narrative of the company's financial health and growth potential. With a market capitalization of $6.77 billion, Doximity boasts a high gross profit margin of 89.65% for the last twelve months as of Q1 2025, underscoring the efficiency of its business model. Additionally, the company has experienced a robust revenue growth of 12.99% during the same period, which aligns with the positive outlook on its fiscal year 2025 guidance.

InvestingPro Tips highlight that Doximity is trading at a P/E ratio of 42.54, which, when adjusted for the last twelve months as of Q1 2025, sits at 40.46. This valuation comes with a backdrop of the company's management aggressively buying back shares and holding more cash than debt on its balance sheet. Furthermore, with 14 analysts having revised their earnings upwards for the upcoming period, the confidence in Doximity's financial prospects is echoed in the analytical community.

For readers interested in a deeper dive into Doximity's financials and future outlook, InvestingPro offers additional tips that can provide a more comprehensive understanding of the company's position and potential. In total, there are 18 additional InvestingPro Tips available for Doximity, which can be accessed for further detailed analysis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.